| J1561 | Injection, immune globulin, (gamunex-c/gammaked), non-lyophilized (e.g., liquid), 500 mg | 14,780 | $40 | $561.8K |
| J3262 | Injection, tocilizumab, 1 mg | 83,960 | $10 | $419.8K |
| J0129 | Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | 7,880 | $30 | $267.8K |
| Q5104 | Injection, infliximab-abda, biosimilar, (renflexis), 10 mg | 4,240 | $30 | $127.2K |
| J1745 | Injection, infliximab, excludes biosimilar, 10 mg | 3,440 | $30 | $89.4K |
| J0897 | Injection, denosumab, 1 mg | 3,900 | $20 | $70.2K |
| 99214 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the… | 470 | $90 | $40.9K |
| 96365 | The provider administers the initial intravenous infusion of a medication or other substance for a period up to one hour to prevent, treat, or diagnose a condition or disease. | 520 | $50 | $24.8K |
| 96413 | Chemotherapy is a therapeutic procedure used for the treatment of cancer via the use of chemical agents. These chemical agents (drugs) work on the cancerous cells of the body to destroy them. These… | 190 | $100 | $18.6K |
| 96366 | The provider administers an intravenous infusion or infusions of a medication for an additional hour or subsequent hours after the first hour to prevent, treat, or diagnose a condition or disease. | 540 | $20 | $8.6K |